Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head | 1 | 2011 | 115 | 0.330 |
Why?
|
| Artifacts | 1 | 2011 | 114 | 0.320 |
Why?
|
| Neck | 1 | 2011 | 142 | 0.320 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 228 | 0.310 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 308 | 0.300 |
Why?
|
| Transplantation Tolerance | 1 | 2005 | 15 | 0.240 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 110 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 2168 | 0.210 |
Why?
|
| Graft Survival | 1 | 2005 | 473 | 0.200 |
Why?
|
| Organ Transplantation | 1 | 2005 | 180 | 0.200 |
Why?
|
| Graft Rejection | 1 | 2005 | 559 | 0.180 |
Why?
|
| Lymph Nodes | 2 | 2008 | 389 | 0.120 |
Why?
|
| Radionuclide Imaging | 3 | 2008 | 144 | 0.090 |
Why?
|
| Indocyanine Green | 2 | 2008 | 63 | 0.080 |
Why?
|
| Biological Transport | 1 | 2011 | 348 | 0.080 |
Why?
|
| Tretinoin | 1 | 2010 | 102 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 134 | 0.080 |
Why?
|
| Fluorescent Dyes | 2 | 2008 | 263 | 0.080 |
Why?
|
| Lymphography | 1 | 2008 | 13 | 0.070 |
Why?
|
| Lymphatic Vessels | 1 | 2008 | 36 | 0.070 |
Why?
|
| Neoplasms | 2 | 2011 | 2955 | 0.060 |
Why?
|
| Transplantation Immunology | 1 | 2005 | 45 | 0.060 |
Why?
|
| Thallium | 1 | 2005 | 8 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2005 | 73 | 0.060 |
Why?
|
| Adenosine | 1 | 2005 | 135 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1519 | 0.050 |
Why?
|
| Chest Pain | 1 | 2004 | 128 | 0.050 |
Why?
|
| Mood Disorders | 1 | 2004 | 129 | 0.050 |
Why?
|
| Exercise Test | 1 | 2004 | 259 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 767 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 1301 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 893 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 1046 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 3736 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2645 | 0.030 |
Why?
|
| Humans | 7 | 2011 | 131985 | 0.020 |
Why?
|
| Male | 4 | 2011 | 64910 | 0.020 |
Why?
|
| Muscles | 1 | 2010 | 238 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 271 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 380 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 302 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 750 | 0.020 |
Why?
|
| Gamma Cameras | 1 | 2008 | 5 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 2008 | 31 | 0.020 |
Why?
|
| Axilla | 1 | 2008 | 42 | 0.020 |
Why?
|
| Sternum | 1 | 2008 | 53 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 82 | 0.020 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2008 | 72 | 0.020 |
Why?
|
| Prevalence | 2 | 2005 | 2658 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 153 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 442 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 326 | 0.020 |
Why?
|
| Texas | 2 | 2005 | 3628 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 602 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 822 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2005 | 170 | 0.010 |
Why?
|
| Swine | 1 | 2008 | 1181 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 328 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1330 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 1361 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 207 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 1796 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 3678 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 958 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1443 | 0.010 |
Why?
|
| Mice | 2 | 2010 | 18461 | 0.010 |
Why?
|
| Middle Aged | 3 | 2008 | 28976 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 1174 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 1160 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 1439 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 2140 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 1609 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 1233 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 1839 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 3011 | 0.010 |
Why?
|
| Animals | 2 | 2010 | 34789 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 7100 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 5008 | 0.010 |
Why?
|
| Female | 3 | 2008 | 70623 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 6569 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 10941 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 21415 | 0.000 |
Why?
|
| Adult | 1 | 2008 | 31547 | 0.000 |
Why?
|